Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Evans Terry L received 168 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded Aug 31, 2026 · Filed Aug 31, 2026

On Aug 31, 2026, Evans Terry L (Chief Commercial Officer) received 168 Fennec Pharmaceuticals Inc. shares as an award, leaving 21,519 shares. Filed Aug 31, 2026 (Form 4).

Awarded
168 shares
Holding after
21,519 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 31, 2026Common SharesAward16821,519Direct

Source

View original at SEC

Related